Panagora Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-29,790
Closed -$54K 2680
2019
Q2
$54K Sell
29,790
-2,153
-7% -$3.47K ﹤0.01% 2077
2019
Q1
$60K Hold
31,943
﹤0.01% 2005
2018
Q4
$38K Buy
31,943
+25,826
+422% +$46.4K ﹤0.01% 2038
2018
Q3
$17K Buy
+6,117
New +$12.7K ﹤0.01% 2253
2017
Q3
Sell
-4,391
Closed -$7K 2538
2017
Q2
$7K Sell
4,391
-3,666
-46% -$7.07K ﹤0.01% 2492
2017
Q1
$26K Hold
8,057
﹤0.01% 2121
2016
Q4
$11K Sell
8,057
-77,487
-91% -$101K ﹤0.01% 2285
2016
Q3
$133K Sell
85,544
-4,504
-5% -$6.92K ﹤0.01% 1890
2016
Q2
$120K Sell
90,048
-38,624
-30% -$181K ﹤0.01% 1854
2016
Q1
$678K Sell
128,672
-285,638
-69% -$1.75M ﹤0.01% 1248
2015
Q4
$3.25M Buy
414,310
+81,592
+25% +$702K 0.02% 664
2015
Q3
$2.81M Buy
332,718
+89,472
+37% +$825K 0.01% 665
2015
Q2
$2.66M Buy
243,246
+121,937
+101% +$1.57M 0.01% 703
2015
Q1
$1.7M Buy
+121,309
New +$1.85M 0.01% 838
2013
Q3
Sell
-47,430
Closed -$771K 2378
2013
Q2
$771K Buy
+47,430
New +$1.47M ﹤0.01% 1164

Other funds holding INFI

Panagora Asset Management's INFI Position: Q3 2019 in Review

Panagora Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2019, closing a stake of 29,790 shares — an estimated $54K sold.

Panagora Asset Management first reported a position in INFI in Q2 2013 and held it in 15 quarters. The position peaked at $3.25M in Q4 2015. 51 funds tracked by Wall St. Rank hold INFI as of Q3 2019.

  • Panagora Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 29,790 Infinity Pharmaceuticals, Inc. shares in Q3 2019, an estimated $54K.
  • Panagora Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 15 quarters.
  • Panagora Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $3.25M in Q4 2015.
  • 51 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.